CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug2717 Standard screening strategy Wiki 1.00
drug1859 New screening strategy Wiki 1.00

Correlated MeSH Terms (5)

Name (Synonyms) Correlation
D003141 Communicable Diseases NIH 0.08
D011014 Pneumonia NIH 0.06
D007239 Infection NIH 0.05
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials

1 Famotidine Use in Non-hospitalized Patients With COVID-19: A Case Series

A retrospective case series of patients who self-medicated with Famotidine during coronavirus disease 2019 (COVID-19). The study will collect de-identified patient reported outcome measures of patients with confirmed COVID-19 who self-medicated with Famotidine at any dose during the period of illness. Data will be collected by questionnaire and telephone interview. Inclusion criteria: Age>18; Ability to give written informed consent for study participation; Confirmed diagnosis of COVID-19; Use of Famotidine at any dose during period of COVID-19 illness

NCT04389567 COVID-19 Drug: Famotidine

Primary Outcomes

Description: Symptoms assessed by severity scores on an ordinal scale; 1=not affected to 4= severely affected

Measure: Symptomatic improvement

Time: 2 weeks

Secondary Outcomes

Description: Oxygen saturation determined by pulse oximetry

Measure: Peripheral blood oxygen saturation

Time: 2 weeks

No related HPO nodes (Using clinical trials)